BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38216411)

  • 21. Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis.
    Ng PLF; Lim YC; Evangelista LKM; Wong RCC; Chai P; Sia CH; Loi HY; Yeo TC; Lin W
    Ann Noninvasive Electrocardiol; 2022 Jul; 27(4):e12967. PubMed ID: 35567784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Senile cardiac amyloidosis: Clinical manifestations and non-invasive diagnostic approach.
    Varvarousis D; Polytarchou K; Daskalopoulos N; Mantas I
    Hellenic J Cardiol; 2017; 58(1):60-64. PubMed ID: 28163147
    [No Abstract]   [Full Text] [Related]  

  • 23. Nuclear imaging in cardiac amyloidosis.
    Glaudemans AW; Slart RH; Zeebregts CJ; Veltman NC; Tio RA; Hazenberg BP; Dierckx RA
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):702-14. PubMed ID: 19156411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and typing of cardiac amyloidosis by noninvasive imaging: Two cases for two patterns.
    Nappi C; Zampella E; Volpe F; De Risi M; Piscopo L; Ponsiglione A; Imbriaco M; Acampa W; Petretta M; Cuocolo A
    J Nucl Cardiol; 2020 Jun; 27(3):915-920. PubMed ID: 31845305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The Changing Appearance of Cardiac Amyloidosis].
    Mahrholdt H; Klingel K; Sechtem U
    Dtsch Med Wochenschr; 2018 Sep; 143(18):1335-1343. PubMed ID: 30199915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Performance of Abnormal Nulling on Cardiac Magnetic Resonance Imaging Look Locker Inversion Time Sequence in Differentiating Cardiac Amyloidosis Types.
    Tavoosi A; Yu B; Aghel N; Karur GR; Pakkal M; Wald R; Wintersperger BJ; Delgado DH; Hanneman K
    J Thorac Imaging; 2020 Sep; 35(5):334-339. PubMed ID: 32195888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Speckle tracking echocardiography in cardiac amyloidosis.
    Stricagnoli M; Cameli M; Incampo E; Lunghetti S; Mondillo S
    Heart Fail Rev; 2019 Sep; 24(5):701-707. PubMed ID: 30989593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac amyloidosis: typical imaging findings and diffuse myocardial damage demonstrated by delayed contrast-enhanced MRI.
    Sueyoshi E; Sakamoto I; Okimoto T; Hayashi K; Tanaka K; Toda G
    Cardiovasc Intervent Radiol; 2006; 29(4):710-2. PubMed ID: 16565801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue Doppler features of cardiac amyloidosis.
    Elliott PM; Mahon NG; Matsumura Y; Hawkins PN; Gillmore JD; McKenna WJ
    Clin Cardiol; 2000 Sep; 23(9):701. PubMed ID: 11016022
    [No Abstract]   [Full Text] [Related]  

  • 30. [Artificial intelligence and radiomics : Value in cardiac MRI].
    Rau A; Soschynski M; Taron J; Ruile P; Schlett CL; Bamberg F; Krauss T
    Radiologie (Heidelb); 2022 Nov; 62(11):947-953. PubMed ID: 36006439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac amyloidosis cases with relative apical sparing of longitudinal strain.
    Bostan C; Sinan UY; Canbolat P; Kucukoglu S
    Echocardiography; 2014 Feb; 31(2):241-4. PubMed ID: 24304289
    [No Abstract]   [Full Text] [Related]  

  • 32. Nuclear imaging modalities for cardiac amyloidosis.
    Bokhari S; Shahzad R; Castaño A; Maurer MS
    J Nucl Cardiol; 2014 Feb; 21(1):175-84. PubMed ID: 24162886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone scintigram in cardiac amyloidosis: a case report.
    Ali A; Turner DA; Rosenbush SW; Fordham EW
    Clin Nucl Med; 1981 Mar; 6(3):105-8. PubMed ID: 6257442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac amyloidosis diagnosed incidentally by bone scintigraphy.
    Wechalekar K; Ng FS; Poole-Wilson PA; Duncan A; Nutting C; Naidoo VV; Underwood SR
    J Nucl Cardiol; 2007; 14(5):750-3. PubMed ID: 17826329
    [No Abstract]   [Full Text] [Related]  

  • 35. Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners.
    Koutelou M; Prassopoulos V; Lamprakos L; Zissimopoulos A; Chatzipanagiotou T; Mastorakou A; Doumas A
    Hell J Nucl Med; 2023; 26(3):166-171. PubMed ID: 38085831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging.
    Legou F; Tacher V; Damy T; Planté-Bordeneuve V; Rappeneau S; Benhaiem N; Rosso J; Itti E; Luciani A; Kobeiter H; Rahmouni A; Deux JF
    Diagn Interv Imaging; 2017 Feb; 98(2):125-132. PubMed ID: 27692958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial Tc-99m MDP uptake on a bone scan in senile systemic amyloidosis with cardiac involvement.
    Ak I; Vardareli E; Erdinĉ O; Kasapoğlu E; Ata N
    Clin Nucl Med; 2000 Oct; 25(10):826-7. PubMed ID: 11043729
    [No Abstract]   [Full Text] [Related]  

  • 38. Can Deep Learning Detect Incidental Abnormal Cardiac Uptake Related to Amyloidosis on Routine Bone Scintigraphy?
    Slomka PJ; Miller RJH
    JACC Cardiovasc Imaging; 2023 Aug; 16(8):1096-1098. PubMed ID: 37558354
    [No Abstract]   [Full Text] [Related]  

  • 39. Magnetic resonance imaging in cardiac amyloidosis.
    Pennell DJ; Maceira AM
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1378-80. PubMed ID: 20083071
    [No Abstract]   [Full Text] [Related]  

  • 40. Emerging Roles for Artificial Intelligence in Heart Failure Imaging.
    Bradley AJ; Ghawanmeh M; Govi AM; Covas P; Panjrath G; Choi AD
    Heart Fail Clin; 2023 Oct; 19(4):531-543. PubMed ID: 37714592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.